Medical Director, Chicago Prostate Cancer Center, Westmont, IL Medical Director, DuPage Medical Group Cancer Center, Lisle, IL
Radiation Oncology
Dr. Brian J. Moran, MD
|
|
Give Review
Brian Moran practices Radiation Oncology. He researched medicine at Loyola University Chicago Stritch School of Medicine. He received 1 awards: "CMS Meaningful Use Stage 1 Certification". Dr. Brian J. Moran has written publications. He has 73 publications published with PubMed. The lastest publication is: 'Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978-1997.' Brian Moran is registered with Medicare.
Publications
- Definition and Validation of "Favorable High-Risk Prostate Cancer": Implications for Personalizing Treatment of Radiation-Managed Patients.
- Establishing high-quality prostate brachytherapy using a phantom simulator training program.
- Neoadjuvant hormonal therapy use and the risk of death in men with prostate cancer treated with brachytherapy who have no or at least a single risk factor for coronary...
- Cardiovascular Comorbidity and Mortality in Men With Prostate Cancer Treated With Brachytherapy-based Radiation With or Without Hormonal Therapy.
- Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy...
- American College of Radiology Appropriateness Criteria(®)--locally advanced (high-risk) prostate cancer.
- ACR Appropriateness Criteria® definitive external beam irradiation in stage T1 and T2 prostate cancer.
- Diabetes mellitus, race and the odds of high grade prostate cancer in men treated with radiation therapy.
- Hormonal Therapy or External-Beam Radiation With Brachytherapy and the Risk of Death From Prostate Cancer in Men With Intermediate Risk Prostate Cancer.
- Outcomes following a limited approach to radiotherapy in rectal cancer.
- Type of Diabetes Mellitus and the Odds of Gleason Score 8 to 10 Prostate Cancer.
- Risk of death from prostate cancer after radical prostatectomy or brachytherapy in men with low or intermediate risk disease.
- Influence of Androgen Deprivation Therapy on All-Cause Mortality in Men with High-Risk Prostate Cancer and a History of Congestive Heart Failure or Myocardial Infarction.
- American College of Radiology Appropriateness Criteria permanent source brachytherapy for prostate cancer.
- Risk of all-cause and prostate cancer-specific mortality after brachytherapy in men with small prostate size.
- Postgraduate multidisciplinary development program: impact on the interpretation of pelvic MRI in patients with rectal cancer: a clinical audit in West Denmark.
- Predictors of the use of supplemental androgen suppression therapy and external beam radiation in men with high-risk prostate cancer undergoing brachytherapy in commun...
- ACR appropriateness criteria postradical prostatectomy irradiation in prostate cancer.
- Multi-institutional experience of diffuse intra-abdominal multicystic peritoneal mesothelioma.
- Prospective longitudinal study of quality of life following cytoreductive surgery and intraperitoneal chemotherapy for pseudomyxoma peritonei.
- Predicting the risk and diminishing the consequences of anastomotic leakage after anterior resection for rectal cancer.
- Androgen-suppression therapy for prostate cancer and the risk of death in men with a history of myocardial infarction or stroke.
- Causes of death in men with prevalent diabetes and newly diagnosed high- versus favorable-risk prostate cancer.
- Prostate cancer-specific mortality and the extent of therapy in healthy elderly men with high-risk prostate cancer.
- Predictors of prostate cancer-specific mortality in elderly men with intermediate-risk prostate cancer treated with brachytherapy with or without external beam radiati...
- The use of supplemental external beam radiotherapy in men with low-risk prostate cancer undergoing brachytherapy before and after the 1999 American Brachytherapy Socie...
- Total androgen blockade versus a luteinizing hormone-releasing hormone agonist alone in men with high-risk prostate cancer treated with radiotherapy.
- Luteinizing-hormone releasing hormone therapy and the risk of death from Alzheimer disease.
- Concomitant rectal cancer and abdominal aortic aneurysm: a management strategy.
- Recombinant tissue plasminogen activator increases blood-brain barrier disruption in acute ischemic stroke: an MR imaging permeability study.
- Cytoreductive surgery and intraperitoneal chemotherapy for peritoneal mesothelioma.
- Hormonal therapy use for prostate cancer and mortality in men with coronary artery disease-induced congestive heart failure or myocardial infarction.
- Risk of death from prostate cancer after brachytherapy alone or with radiation, androgen suppression therapy, or both in men with high-risk disease.
- Stereotactic transperineal prostate biopsy.
- Staple line haemorrhage following laparoscopic left-sided colorectal resections may be more common when the inferior mesenteric artery is preserved.
- Recommendations for permanent prostate brachytherapy with (131)Cs: a consensus report from the Cesium Advisory Group.
- Sites of surgical wasting in the abdominoperineal specimen.
- Variations in pelvic dimensions do not predict the risk of circumferential resection margin (CRM) involvement in rectal cancer.
- Accurate staging, selective preoperative therapy and optimal surgery improves outcome in rectal cancer: a review of the recent evidence.
- Long-term results show triple stapling facilitates safe low colorectal and coloanal anastomosis and is associated with low rates of local recurrence after anterior res...
- Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation.
- Interstitial implant alone or in combination with external beam radiation therapy for intermediate-risk prostate cancer: a survey of practice patterns in the United St...
- Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Soci...
- Long-term storage and safe retrieval of DNA from microorganisms for molecular analysis using FTA matrix cards.
- Magnetic resonance imaging pelvimetry in 186 patients with rectal cancer confirms an overlap in pelvic size between males and females.
- Re-biopsy of the prostate using a stereotactic transperineal technique.
- Hyperthermic intraperitoneal chemotherapy and cytoreductive surgery for peritoneal carcinomatosis of colorectal origin: a novel treatment strategy with promising resul...
- Comparison of biochemical failure definitions for permanent prostate brachytherapy.
- Operability and early outcome in 100 consecutive laparotomies for peritoneal malignancy.
- Almost all five year disease free survivors are cured following rectal cancer surgery, but longer term follow-up detects some late local and systemic recurrences.
- Impact of a surgical training programme on rectal cancer outcomes in Stockholm.
- Variability of prostate brachytherapy pre-implant dosimetry: a multi-institutional analysis.
- Management and imaging of low rectal carcinoma.
- Surgery alone: is total mesorectal excision sufficient for rectal cancer?
- Prostate brachytherapy can be performed in selected patients after transurethral resection of the prostate.
- Interferon gamma-1b as therapy for idiopathic pulmonary fibrosis. An intrapatient analysis.
- Seed loss through the urinary tract after prostate brachytherapy: examining the role of cystoscopy and urine straining post implant.
- Optimal preoperative assessment and surgery for rectal cancer may greatly limit the need for radiotherapy.
- An innovative dosimetric model for formulating a semi-analytical solution for the activity-volume relationship in prostate implants.
- A 5-cm colonic J pouch colo-anal reconstruction following anterior resection for low rectal cancer results in acceptable evacuation and continence in the long term.
- Interobserver variability leads to significant differences in quantifiers of prostate implant adequacy.
- The contribution of genetic factors to thrombotic and bleeding outcomes in coronary patients randomised to IIb/IIIa antagonists.
- Postoperative adhesions: ten-year follow-up of 12,584 patients undergoing lower abdominal surgery.
- Surgical decisions in the elderly: the importance of biological age.
- 125 Gy or 135 Gy? Comments on the American Brachytherapy Society article by Beyer et al. IJROBP 2000;47:273-275.
- Stoma-related complications are more frequent after transverse colostomy than loop ileostomy: a prospective randomized clinical trial.
- Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm. Stockholm Colorectal Cancer Study Group, Basingstoke Bowel Cancer Resea...
- Comment on "Permanent prostate seed implant brachytherapy: report of the American Association of Physicists in Medicine Task Group No. 64" [Med. Phys. 26, 2054-2076 (1...
- Comparisons of a proposed five-seed assay method with the single-seed and batch assay methods for I-125 seeds in ultrasound-guided prostate implants.
- Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978-1997.
- Local recurrence after anterior resection for rectal cancer using a double stapling technique.
- Through-knee amputation in high-risk patients with vascular disease: indications, complications and rehabilitation.
Schools
Loyola Univ Of Chicago Stritch Sch Of Med
Rush Macneal Med Center
Loyola Hines Med Center
Doctors Specialties
- Radiation Oncology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Loyola University Chicago Stritch School of Medicine
Drug Facts
| NPI NUMBER | 1093712671 | |
| NPPES Provider LastName | MORAN | |
| NPPES Provider FirstName | BRIAN | |
| NPPES Provider ZIPCode | 605591276 | |
| NPPES Provider State | IL | |
| Specialty Description | Radiation Oncology | |
| Total Claim Count | 937.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1093712671 |
| Last Name Of The Provider | MORAN |
| First Name Of The Provider | BRIAN |
| View All |
Similar Doctors
|
|
Dr. Katherine F. Baker, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anand P. Shah, MD
This Doctor is OpenDoctor Recommended.
|